WEBINAR
Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab
This webinar for healthcare providers will provide information specific to the Health Canada recently approved biosimilar for denosumab.
Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment plans, what healthcare providers need to communicate with their patients and more.
Webinar Details
Date: Tuesday, October 22, 2024
Time:
10:30 am – 11:30 am PT
11:30 am – 12:30 pm MT
12:30 pm – 1:30 pm CT
1:30 pm – 2:30 pm ET
2:30 pm – 3:30 pm AT
3:00 pm – 4:00 pm NT
PRESENTER
Angela Cheung MD, PhD, FRCPC
Dr. Angela M. Cheung is Professor of Medicine, KY and Betty Ho Chair in Integrative Medicine at University of Toronto and Senior Physician Scientist at University Health Network. She is the Founding Director of the Osteoporosis Program at University Health Network and the Founding Director of the Centre of Excellence in Skeletal Health Assessment at University of Toronto. She obtained her MD from Johns Hopkins University in 1988 and her PhD from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for >30 years.
She has won many research, teaching and mentorship awards over the years, including the 2024 ASBMR Gideon Rodan’s Mentorship Award, the 2023 European Calcified Tissue Society (ECTS) Research Excellence Award, Canadian Institutes of Health Research (CIHR) Senior Investigator award, Canadian Society of Internal Medicine (CSIM) Dr. David Sackett Senior Investigator Award, Ontario Premier Research Excellence Award, University of Toronto (U of T) Eaton Scholar Award in Clinical Research, University Health Network (UHN) Excellence in Clinical Teaching award, U of T Eudenie Stuart Mentorship award and UHN/Sinai Health System Michael Hutcheon Mentorship award. She currently holds a Tier 1 Canada Research Chair in Postmenopausal and Musculoskeletal Health.
Dr. Cheung was the past chair of Osteoporosis Canada Scientific Advisory Council. She is a current member of the International Osteoporosis Foundation Council of Scientific Advisors and the President-Elect for International Society of Clinical Densitometry. She has published over 250 peer-reviewed manuscripts and has a h-index of 75. Her research interests are in postmenopausal osteoporosis, atypical femur fractures and rare bone diseases.